Ikuko Tsukamoto

1.2k total citations
53 papers, 1.0k citations indexed

About

Ikuko Tsukamoto is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Spectroscopy. According to data from OpenAlex, Ikuko Tsukamoto has authored 53 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Spectroscopy. Recurrent topics in Ikuko Tsukamoto's work include Diet, Metabolism, and Disease (13 papers), Liver Disease Diagnosis and Treatment (7 papers) and Molecular Sensors and Ion Detection (6 papers). Ikuko Tsukamoto is often cited by papers focused on Diet, Metabolism, and Disease (13 papers), Liver Disease Diagnosis and Treatment (7 papers) and Molecular Sensors and Ion Detection (6 papers). Ikuko Tsukamoto collaborates with scholars based in Japan, China and United States. Ikuko Tsukamoto's co-authors include Masaaki Tokuda, Fuminori Yamaguchi, Youyi Dong, Kazuyo Kamitori, Akram Hossain, Yuko Hirata, Yukiyasu Toyoda, Li Sui, Naoya Hatano and Yasuo Nagata and has published in prestigious journals such as Scientific Reports, Brain Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Ikuko Tsukamoto

50 papers receiving 987 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ikuko Tsukamoto Japan 16 601 294 230 137 127 53 1.0k
T. Geoffrey Flynn Canada 19 360 0.6× 970 3.3× 308 1.3× 54 0.4× 80 0.6× 47 2.4k
Matthew Blatnik United States 12 164 0.3× 462 1.6× 254 1.1× 159 1.2× 116 0.9× 17 893
Yuki Izawa Japan 21 189 0.3× 478 1.6× 275 1.2× 35 0.3× 117 0.9× 27 1.1k
Yusuke Moritoh Japan 18 496 0.8× 420 1.4× 116 0.5× 61 0.4× 455 3.6× 30 939
Teresa C. Delgado Spain 16 112 0.2× 346 1.2× 226 1.0× 258 1.9× 80 0.6× 41 867
Jiro Endo Japan 15 239 0.4× 336 1.1× 135 0.6× 55 0.4× 84 0.7× 68 834
Albert Barberà Spain 14 175 0.3× 220 0.7× 152 0.7× 41 0.3× 197 1.6× 20 723
Erkan Tuncay Türkiye 20 174 0.3× 639 2.2× 183 0.8× 75 0.5× 143 1.1× 66 1.2k
Xuming Jia Canada 12 163 0.3× 253 0.9× 217 0.9× 76 0.6× 58 0.5× 17 1.1k
Hirotaka Tsubouchi Japan 8 208 0.3× 232 0.8× 269 1.2× 72 0.5× 162 1.3× 9 827

Countries citing papers authored by Ikuko Tsukamoto

Since Specialization
Citations

This map shows the geographic impact of Ikuko Tsukamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ikuko Tsukamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ikuko Tsukamoto more than expected).

Fields of papers citing papers by Ikuko Tsukamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ikuko Tsukamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ikuko Tsukamoto. The network helps show where Ikuko Tsukamoto may publish in the future.

Co-authorship network of co-authors of Ikuko Tsukamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Ikuko Tsukamoto. A scholar is included among the top collaborators of Ikuko Tsukamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ikuko Tsukamoto. Ikuko Tsukamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyashita, Takenori, et al.. (2024). Systemically Administered D-allose Inhibits the Tumor Energy Pathway and Exerts Synergistic Effects With Radiation. Anticancer Research. 44(5). 1895–1903.
2.
Umakoshi, Takayuki, et al.. (2023). Raman Spectroscopic and DFT Study of COA-Cl and Its Analogues. The Journal of Physical Chemistry A. 127(8). 1849–1856. 1 indexed citations
3.
Kato, Kentaro, et al.. (2023). Effects of monosaccharides including rare sugars on proliferation of Entamoeba histolytica trophozoites in vitro. Frontiers in Molecular Biosciences. 10. 1288470–1288470. 1 indexed citations
4.
Jamal, Mostofa, et al.. (2022). COA-Cl Evokes Protective Responses Against H2O2-and 6-OHDA-Induced Toxic Injury in PC12 Cells. Neurotoxicity Research. 40(6). 2061–2071. 2 indexed citations
5.
Himi, Naoyuki, et al.. (2020). The protective effect and mechanism of COA-Cl in acute phase after spinal cord injury. Neuroscience Research. 170. 114–121. 5 indexed citations
6.
Nishikido, Toshiyuki, Jun‐ichi Oyama, Aya Shiraki, et al.. (2019). COA-Cl (2-Cl-C.OXT-A) can promote coronary collateral development following acute myocardial infarction in mice. Scientific Reports. 9(1). 2533–2533. 4 indexed citations
8.
Kamitori, Kazuyo, Fuminori Yamaguchi, Youyi Dong, et al.. (2018). Both Ser361 phosphorylation and the C‐arrestin domain of thioredoxin interacting protein are important for cell cycle blockade at the G1/S checkpoint. FEBS Open Bio. 8(11). 1804–1819. 13 indexed citations
9.
Kawami, Masashi, Ryoko Yumoto, Norikazu Sakakibara, et al.. (2017). Effect of COA-Cl on transforming growth factor-β1-induced epithelial–mesenchymal transition in RLE/Abca3 cells. Drug Metabolism and Pharmacokinetics. 32(4). 224–227. 7 indexed citations
10.
Hossain, Akram, Fuminori Yamaguchi, Tatsuhiro Matsuo, et al.. (2015). Rare sugar d-allulose: Potential role and therapeutic monitoring in maintaining obesity and type 2 diabetes mellitus. Pharmacology & Therapeutics. 155. 49–59. 159 indexed citations
11.
Hasan, Arif Ul, Koji Ohmori, Junsuke Igarashi, et al.. (2015). Eicosapentaenoic acid upregulates VEGF-A through both GPR120 and PPARγ mediated pathways in 3T3-L1 adipocytes. Molecular and Cellular Endocrinology. 406. 10–18. 59 indexed citations
12.
Hossain, Akram, Ikuko Tsukamoto, Fuminori Yamaguchi, et al.. (2014). Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose. Drug Design Development and Therapy. 8. 1955–1955. 42 indexed citations
13.
Okabe, N., Emi Nakamura, Naoyuki Himi, et al.. (2013). Delayed administration of the nucleic acid analog 2Cl-C.OXT-A attenuates brain damage and enhances functional recovery after ischemic stroke. Brain Research. 1506. 115–131. 17 indexed citations
14.
Ueno, Masaki, Nozomu Nishi, Toshitaka Nakagawa, et al.. (2013). Immunoreactivity of glucose transporter 5 is located in epithelial cells of the choroid plexus and ependymal cells. Neuroscience. 260. 149–157. 22 indexed citations
15.
Hoshikawa, Hiroshi, Terushige Mori, Ikuko Tsukamoto, et al.. (2009). Growth inhibition of head and neck carcinomas by D‐allose. Head & Neck. 31(8). 1049–1055. 38 indexed citations
16.
Kitamura, Yoshihisa, Masaki Mifune, Ikuko Tsukamoto, et al.. (2006). Effect of octabromination of a tetrakis(4-carboxyphenyl)porphine derivative bound to silica gels on HPLC retention behaviors of polyaromatic hydrocarbons. Talanta. 69(5). 1260–1264. 5 indexed citations
17.
Tsukamoto, Ikuko, Madoka Saito, Yoshihisa Kitamura, et al.. (2006). HPLC Retention Behaviors of p-Electron Rich Compounds on Ni2+- and Cu2+-Phthalocyanine Derivatives Bound to Silica Gels in Polar Eluents. Analytical Sciences. 22(7). 1035–1038. 1 indexed citations
18.
Tsukamoto, Ikuko, et al.. (1998). Effects of halothane and supporting membrane lipids on the activity of acetylcholinesterase. Toxicology Letters. 100-101. 447–450. 5 indexed citations
19.
Tsukamoto, Ikuko, et al.. (1991). The effects of age and anesthetic solubility on anesthetic-induced opisthotonus in mice. Journal of Anesthesia. 5(3). 228–232. 4 indexed citations
20.
Tsukamoto, Ikuko, et al.. (1989). A kinetic study on secretion and elimination of endogenous thyrotropin in the thyrotropin-releasing hormone test. Annals of Nuclear Medicine. 3(1). 9–13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026